Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
GSK cancer drug receives expanded approval from the US regulator
03:41am, Friday, 02'nd Aug 2024
The US Food and Drug Administration (FDA) has expanded the approval of GSK PLC (LSE:GSK, NYSE:GSK)'s Jemperli (dostarlimab) in combination with chemotherapy for the treatment of adult patients with pr
Here's Why GSK (GSK) is a Strong Value Stock
10:42am, Thursday, 01'st Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GSK Q2 Earnings Review: Vaccine Issues Aside, A Strong Quarter
03:38pm, Wednesday, 31'st Jul 2024
UK-based Pharma giant GSK plc reported its Q2 earnings earlier today. GSK plc exceeded Q2 2024 expectations with revenue up 13%, operating profit up 18%, and EPS up 17%. GSK upgraded full-year guidanc
GSK: Good Earnings Report, But Risks Ahead (Rating Downgrade)
01:29pm, Wednesday, 31'st Jul 2024
GSK's H1 2024 earnings report is strong, with healthy sales growth, solid core EPS increase, and upgraded outlook, resulting in attractive market multiples. However, the outlook still indicates that i
GSK plc (GSK) Q2 2024 Earnings Call Transcript
12:24pm, Wednesday, 31'st Jul 2024
GSK plc (NYSE:GSK ) Q2 2024 Earnings Conference Call July 31, 2024 7:00 AM ET Company Participants Nick Stone - Head, IR Emma Walmsley - CEO Tony Wood - Chief Scientific Officer Luke Miels - Chief Com
GSK sees £1.2bn wiped from its value as investors grumble about vaccine miss
11:07am, Wednesday, 31'st Jul 2024
Around £1.2 billion was wiped from the value of GSK PLC (LSE:GSK, NYSE:GSK) after the drug giant's Q2 vaccine sales failed to pass muster with the City. Specifically, analysts at Shore Capital said t
GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance
10:26am, Wednesday, 31'st Jul 2024
GSK's revenues benefit from strong growth across the Specialty Medicines and General Medicines segments. It raises guidance for earnings and sales for the full year.
GSK Becomes Latest Pharma Firm To Lift Outlook
09:16am, Wednesday, 31'st Jul 2024
GSK (GSK) lifted its sales and earnings projections for the year, after a strong performance by its HIV and cancer drugs drove second-quarter sales higher.
GSK (GSK) Tops Q2 Earnings and Revenue Estimates
08:05am, Wednesday, 31'st Jul 2024
GSK (GSK) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $0.97 per share a year ago.
GSK's better-than-expected results overshadowed by Zantac litigation
05:45am, Wednesday, 31'st Jul 2024
GSK shares fell Wednesday as investors concerns' about lawsuits surrounding the pharmaceutical giant's discontinued heartburn drug Zantac outweighed any positive impacts from its better-than-expected
GSK forecast upgrade fails to impress the market
03:29am, Wednesday, 31'st Jul 2024
GSK PLC (LSE:GSK, NYSE:GSK) has raised its annual earnings and sales forecasts after a strong second-quarter performance driven by cancer and HIV treatments. However, the performance singularly failed
GSK raises annual profit and sales forecast after second quarter beat
02:11am, Wednesday, 31'st Jul 2024
British drugmaker GSK raised its annual earnings and sales forecasts on Wednesday and posted second-quarter results that beat market expectations, boosted by its cancer and HIV portfolio.
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
02:35pm, Tuesday, 30'th Jul 2024
Let's focus on biotech stocks like GSK, VRTX, BIIB, MRNA and REGN, which are scheduled to report this week.
3 Biotech Names With Potential Catalysts By Year End
03:32pm, Monday, 29'th Jul 2024
The huge sector rotation we have seen in the market over the past few weeks has significantly benefited the SPDR® S&P Biotech ETF. If this trend continues, small-cap names within the sector should co
GSK reaches confidential settlement in Illinois
04:14am, Monday, 29'th Jul 2024
GSK PLC (LSE:GSK, NYSE:GSK) said it has reached a confidential settlement with Ronald Kimbrow resolving the case he filed in Illinois state court, which is part of the drug giant's long-running Zanta
